← Eichor
Study identifier: NCT07057544 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

UHF ECG in LBBB and Response to CRT Prediction

Condition: Left Bundle Branch Block · Left Bundle Branch Area Pacing · Biventricular Pacing  ·  Sponsor: Faculty Hospital Kralovske Vinohrady

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main objective of the project is to demonstrate that in patients with heart failure and QRS complex of nonRBBB morphology lasting over 130 ms, UHF-ECG can differentiate patients with trueLBBB from IVCD better than existing approaches based on the assessment of QRS complex morphology and duration from 12-lead ECG. Another goal of the proposed study is to demonstrate that trueLBBB patients will benefit more from CRT using left bundle branch pacing than from CRT using biventricular pacing. The final aim of the project is to demonstrate that the echocardiographic and clinical response in patients with intraventricular conduction disturbance will be dependent on the degree of reduction in ventricular dyssynchrony after CRT.

This description comes directly from the study's public registry record.

Talk to the study team

Karol Curila, MD  ·  +420777869171  ·  karol.curila@fnkv.cz

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty Hospital Kralovske VinohradyPrague, Česká Republika, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07057544